A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT06311734 · COMPLETED
Trial details
- NCT number
- NCT06311734
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2024-01-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.